These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8758407)

  • 1. [Comparison between the plaque reduction neutralization test and the hemagglutination inhibition test in determination of human anti-measles antibodies].
    Kong J; Guo SH; Ze WY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Apr; 17(2):105-7. PubMed ID: 8758407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new neutralization test for measles virus.
    Fujino M; Yoshida N; Kimura K; Zhou J; Motegi Y; Komase K; Nakayama T
    J Virol Methods; 2007 Jun; 142(1-2):15-20. PubMed ID: 17320979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the immunization effect of measles vaccine by capture-EIA].
    Fang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):297-9. PubMed ID: 1300252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of revaccinating children who initially received measles vaccine before 10 months of age.
    Stetler HC; Orenstein WA; Bernier RH; Herrmann KL; Sirotkin B; Hopfensperger D; Schuh R; Albrecht P; Lievens AW; Brunell PA
    Pediatrics; 1986 Apr; 77(4):471-6. PubMed ID: 3960615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive acquired immunity against measles in infants born to naturally infected and vaccinated mothers.
    Szenborn L; Tischer A; Pejcz J; Rudkowski Z; Wójcik M
    Med Sci Monit; 2003 Dec; 9(12):CR541-6. PubMed ID: 14646978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
    Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
    J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The transmission of maternal measles antibodies to newborn infants in the Ivory Coast].
    Rey JL; Lhuillier M; Dem M; Soro B; Saki Z; Davis CE
    Med Trop (Mars); 1991; 51(2):215-8. PubMed ID: 1654494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres.
    Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles antibodies in nasal secretions and sera of children with measles.
    Polna I; Aleksandrowicz J; Krawczyński K; Krotochwil-Skrzypek M; Rozskowska K
    Acta Virol; 1977 Jul; 21(4):331-7. PubMed ID: 20768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on measles immune status by ELISA].
    Li GQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):105-8. PubMed ID: 2736614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of UV-inactivated measles virus.
    Zahorska R; Mazur N; Korbecki M
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):424-30. PubMed ID: 696055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali.
    Tapia MD; Sow SO; Medina-Moreno S; Lim Y; Pasetti MF; Kotloff K; Levine MM
    Am J Trop Med Hyg; 2005 Jul; 73(1):26-31. PubMed ID: 16014826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme immunoassay--a method of serological survey of measles vaccination.
    Vedunova SL; Mikheeva IV; Maltseva NN
    Acta Virol; 1990 Feb; 34(1):95-8. PubMed ID: 1975731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of adsorbents on IgM and IgG measles antibodies.
    Polna I; Aleksandrowicz J
    Acta Virol; 1975 Nov; 19(6):449-56. PubMed ID: 1989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of an automatable focus reduction neutralisation test for the detection of measles virus antibodies using imaging analysis.
    Terletskaia-Ladwig E; Enders G; Meier S; Dietz K; Enders M
    J Virol Methods; 2011 Dec; 178(1-2):124-8. PubMed ID: 21939689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Presence of measles virus antibodies in a group of patients with malignant hemopathy].
    Ribas MA; Ustariz C; Torres G; García D; Tejero Y; Rodríguez C
    Rev Cubana Med Trop; 2000; 52(3):211-4. PubMed ID: 11826525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardization of neutralization tests using the COBL cell line and comparison with the particle agglutination test for measles serology].
    Korukluoğlu G; Yalçinkaya T; Ozkaya E; Kurtoğlu D; Gözalan A; Miyamura K
    Mikrobiyol Bul; 2002 Apr; 36(2):193-9. PubMed ID: 12652872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.